XPC

XPC complex subunit, DNA damage recognition and repair factor, the group of Xeroderma pigmentosum complementation groups

Basic information

Region (hg38): 3:14145145-14178621

Links

ENSG00000154767NCBI:7508OMIM:613208HGNC:12816Uniprot:Q01831AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • xeroderma pigmentosum group C (Definitive), mode of inheritance: AR
  • xeroderma pigmentosum group C (Definitive), mode of inheritance: AR
  • xeroderma pigmentosum group C (Strong), mode of inheritance: AR
  • xeroderma pigmentosum group C (Strong), mode of inheritance: AR
  • xeroderma pigmentosum (Supportive), mode of inheritance: AR
  • xeroderma pigmentosum group C (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Xeroderma pigmentosum, group CARDermatologic; Oncologic; OphthalmologicSkin lesions can be treated (and possibly prevented in some cases) with a variety of methods, depending on the specific type of lesion; Sun/UV exposure (and other agents, such as tobacco smoke) should be avoided; Periodic surveillance (primarily related to skin manifestations, as well as other sequelae) can be beneficialDermatologic; Neurologic; Oncologic; Ophthalmologic7389185; 6696469; 8298653; 9804340; 10766188; 11511294; 14662655; 20301571; 21482201; 22211393; 23143338; 23173980; 23436679

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the XPC gene.

  • not provided (77 variants)
  • Xeroderma pigmentosum, group C (31 variants)
  • Xeroderma pigmentosum (12 variants)
  • XPC-related disorder (2 variants)
  • See cases (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the XPC gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
362
clinvar
7
clinvar
371
missense
2
clinvar
118
clinvar
15
clinvar
6
clinvar
141
nonsense
29
clinvar
21
clinvar
2
clinvar
52
start loss
4
clinvar
4
frameshift
55
clinvar
38
clinvar
2
clinvar
95
inframe indel
9
clinvar
9
splice donor/acceptor (+/-2bp)
5
clinvar
39
clinvar
2
clinvar
46
splice region
1
6
44
2
53
non coding
1
clinvar
16
clinvar
174
clinvar
34
clinvar
225
Total 89 105 151 551 47

Highest pathogenic variant AF is 0.0000591

Variants in XPC

This is a list of pathogenic ClinVar variants found in the XPC region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
3-14145149-T-C Xeroderma pigmentosum, group C Uncertain significance (Jan 13, 2018)343548
3-14145185-A-G Xeroderma pigmentosum, group C Uncertain significance (Jan 13, 2018)343549
3-14145257-C-G Xeroderma pigmentosum • Arrhythmogenic right ventricular cardiomyopathy • Xeroderma pigmentosum, group C Benign/Likely benign (Jan 13, 2018)343550
3-14145259-T-C Xeroderma pigmentosum, group C Uncertain significance (Jan 13, 2018)900776
3-14145293-G-A Xeroderma pigmentosum, group C Uncertain significance (Jan 12, 2018)900777
3-14145317-T-G Xeroderma pigmentosum, group C Uncertain significance (Jul 07, 2021)900778
3-14145323-T-C Xeroderma pigmentosum • Arrhythmogenic right ventricular cardiomyopathy • Xeroderma pigmentosum, group C Benign/Likely benign (Jan 12, 2018)343551
3-14145330-A-G Xeroderma pigmentosum, group C Uncertain significance (Apr 27, 2017)900779
3-14145330-A-T Xeroderma pigmentosum • Arrhythmogenic right ventricular cardiomyopathy • Xeroderma pigmentosum, group C Benign/Likely benign (Jan 12, 2018)343552
3-14145458-T-G Xeroderma pigmentosum, group C Uncertain significance (Jan 12, 2018)343553
3-14145489-C-T Xeroderma pigmentosum, group C Uncertain significance (Jan 13, 2018)343554
3-14145513-C-T Xeroderma pigmentosum Uncertain significance (Jun 14, 2016)343555
3-14145529-C-CT Xeroderma pigmentosum Uncertain significance (Jun 14, 2016)343556
3-14145540-AAACG-A Arrhythmogenic right ventricular cardiomyopathy Likely benign (Jun 14, 2016)369401
3-14145671-T-C Xeroderma pigmentosum, group C Likely benign (Jan 13, 2018)343557
3-14145749-A-G Arrhythmogenic right ventricular cardiomyopathy • Xeroderma pigmentosum • Xeroderma pigmentosum, group C Likely benign (Feb 28, 2019)343558
3-14145785-C-T Xeroderma pigmentosum, group C Uncertain significance (Oct 31, 2018)550681
3-14145802-C-A Xeroderma pigmentosum, group C Uncertain significance (Feb 02, 2018)902445
3-14145808-C-T Arrhythmogenic right ventricular cardiomyopathy • Xeroderma pigmentosum • Xeroderma pigmentosum, group C Conflicting classifications of pathogenicity (Jan 13, 2018)343559
3-14145845-G-C Arrhythmogenic right ventricular cardiomyopathy • Xeroderma pigmentosum • Xeroderma pigmentosum, group C Benign/Likely benign (Dec 05, 2021)343560
3-14145852-C-G Xeroderma pigmentosum, group C Uncertain significance (Jan 13, 2018)343561
3-14145949-G-T not specified • Arrhythmogenic right ventricular cardiomyopathy • Xeroderma pigmentosum • Xeroderma pigmentosum, group C Benign/Likely benign (Feb 01, 2024)190215
3-14145950-C-T Likely benign (Sep 19, 2023)1078103
3-14145956-T-C Likely benign (Oct 07, 2023)2744461
3-14145965-G-A Likely benign (Jul 14, 2023)2889647

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
XPCprotein_codingprotein_codingENST00000285021 1633637
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
3.69e-110.9961246690861247550.000345
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.6954835280.9150.00003046115
Missense in Polyphen153183.910.831942051
Synonymous0.1252002020.9890.00001161846
Loss of Function2.702443.20.5560.00000236526

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.001110.00110
Ashkenazi Jewish0.0007970.000795
East Asian0.00005560.0000554
Finnish0.00009280.0000928
European (Non-Finnish)0.0003590.000345
Middle Eastern0.00005560.0000554
South Asian0.0004270.000425
Other0.0001660.000165

dbNSFP

Source: dbNSFP

Function
FUNCTION: Involved in global genome nucleotide excision repair (GG-NER) by acting as damage sensing and DNA-binding factor component of the XPC complex. Has only a low DNA repair activity by itself which is stimulated by RAD23B and RAD23A. Has a preference to bind DNA containing a short single-stranded segment but not to damaged oligonucleotides. This feature is proposed to be related to a dynamic sensor function: XPC can rapidly screen duplex DNA for non-hydrogen-bonded bases by forming a transient nucleoprotein intermediate complex which matures into a stable recognition complex through an intrinsic single-stranded DNA- binding activity.;
Disease
DISEASE: Xeroderma pigmentosum complementation group C (XP-C) [MIM:278720]: An autosomal recessive pigmentary skin disorder characterized by solar hypersensitivity of the skin, high predisposition for developing cancers on areas exposed to sunlight and, in some cases, neurological abnormalities. The skin develops marked freckling and other pigmentation abnormalities. {ECO:0000269|PubMed:10447254, ECO:0000269|PubMed:10766188, ECO:0000269|PubMed:17355181, ECO:0000269|PubMed:17682058, ECO:0000269|PubMed:19609301, ECO:0000269|PubMed:8298653}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Nucleotide excision repair - Homo sapiens (human);DNA Repair;SUMOylation of DNA damage response and repair proteins;Post-translational protein modification;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;SUMOylation;DNA Damage Recognition in GG-NER;Formation of Incision Complex in GG-NER;Global Genome Nucleotide Excision Repair (GG-NER);Nucleotide Excision Repair (Consensus)

Recessive Scores

pRec
0.484

Intolerance Scores

loftool
0.960
rvis_EVS
0.45
rvis_percentile_EVS
78.04

Haploinsufficiency Scores

pHI
0.282
hipred
Y
hipred_score
0.608
ghis
0.483

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.808

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Xpc
Phenotype
homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); neoplasm; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);

Gene ontology

Biological process
nucleotide-excision repair, DNA damage recognition;DNA repair;nucleotide-excision repair;nucleotide-excision repair, preincision complex assembly;mismatch repair;response to UV-B;response to auditory stimulus;intra-S DNA damage checkpoint;response to drug;global genome nucleotide-excision repair;UV-damage excision repair;regulation of mitotic cell cycle phase transition
Cellular component
nucleotide-excision repair complex;nucleotide-excision repair factor 2 complex;nucleus;nucleoplasm;nucleolus;cytoplasm;mitochondrion;plasma membrane;intracellular membrane-bounded organelle;XPC complex
Molecular function
heteroduplex DNA loop binding;bubble DNA binding;damaged DNA binding;single-stranded DNA binding;protein binding;protein-containing complex binding